Dna X (SONM) Change in Account Payables (2018 - 2026)

Dna X's Change in Account Payables history runs 9 years deep, the most recent figure standing at -$2.7 million for Q1 2026.

• Quarterly Change in Account Payables rose 52.23% year-over-year to -$2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.4 million (up 51.33% YoY) and the FY2025 annual result came in at $9.5 million, down 33.39% from the prior year.
• Change in Account Payables was -$2.7 million for Q1 2026 at Dna X, down from $12.0 million in the prior quarter.
• Across five years, Change in Account Payables topped out at $13.8 million in Q4 2024 and bottomed at -$5.6 million in Q1 2025.
• A 5-year average of $1.9 million and a median of $311000.0 in 2023 frame the typical range for Change in Account Payables.
• Peak annual rise in Change in Account Payables reached 3769.41% in 2025, while the deepest fall reached 1128.52% in 2025.
• Dna X's Change in Account Payables stood at $8.7 million in 2022, then sank by 139.22% to -$3.4 million in 2023, then surged by 504.58% to $13.8 million in 2024, then retreated by 13.2% to $12.0 million in 2025, then slumped by 122.16% to -$2.7 million in 2026.
• Business Quant data shows SONM's Change in Account Payables at -$2.7 million in Q1 2026, $12.0 million in Q4 2025, and -$175000.0 in Q3 2025.